$55.39
-2.97-5.09%
In chiusura: Nov 20, 4:00 PM EST

The average analyst price target for Vaxcyte is $122.18, 119.3% above the current price. Of 9 analysts, 8 rate it Buy and 1 Hold. Targets range from $38 to $175. The latest change came on Oct 5, 2026, when Needham raised its price target on Vaxcyte from $110 to $122 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 9 Analysts
Rating Trend — Last 9 Months